Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Equity Ratio (2021 - 2025)

Senti Biosciences has reported Equity Ratio over the past 5 years, most recently at 0.11 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.11 for Q4 2025, down 58.38% from a year ago — trailing twelve months through Dec 2025 was 0.11 (down 58.38% YoY), and the annual figure for FY2025 was 0.11, down 58.38%.
  • Equity Ratio for Q4 2025 was 0.11 at Senti Biosciences, down from 0.15 in the prior quarter.
  • Over the last five years, Equity Ratio for SNTI hit a ceiling of 0.76 in Q2 2022 and a floor of 212.07 in Q1 2021.
  • Median Equity Ratio over the past 5 years was 0.41 (2025), compared with a mean of 10.36.
  • Biggest five-year swings in Equity Ratio: skyrocketed 295.04% in 2022 and later tumbled 58.38% in 2025.
  • Senti Biosciences' Equity Ratio stood at 1.15 in 2021, then skyrocketed by 161.07% to 0.7 in 2022, then decreased by 20.44% to 0.56 in 2023, then tumbled by 53.19% to 0.26 in 2024, then crashed by 58.38% to 0.11 in 2025.
  • The last three reported values for Equity Ratio were 0.11 (Q4 2025), 0.15 (Q3 2025), and 0.36 (Q2 2025) per Business Quant data.